Bristol-Myers Squibb Company (BMY) Stock Analysis

Bristol-Myers Squibb Company (BMY) Stock Analysis — AI Research | MarketCI

BMY

Market Closed

Bristol-Myers Squibb Company

NYSEHealthcare Drug Manufacturers - General

34.10K employees

CEO: Christopher S. Boerner

Founded: 1972

$54.00

+$0.00(+NaN%)

Market Cap

110.27B

Beta

0.24

52W Range

N/A

Dividend Yield

4.63%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

BMY Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for BMY built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$279.89

AI Price Target

Machine learning • Price prediction

$51.93

Market Sentiment

News & social media analysis

0.15

Value Investor Price

Classic value analysis

$17.02

Financial Health

Bankruptcy risk assessment

2.41

Quality Score

Financial strength rating

8.00

AI Investment Grade

Deep analysis of filings & news

65.00

Key Investment Highlights

Important factors affecting BMY investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

62.79% Good

Conditions Met

27.00/43.00

Due Diligence Score

62.79%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Pass
	Fail
	Pass
	Fail

Showing 1 to 6 of 46 conditions